Literature DB >> 20217283

A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy.

Haruyuki Fujita1, Momoko Nishikori, Akifumi Takaori-Kondo, Noriyoshi Yoshinaga, Yoshiaki Ohara, Takayuki Ishikawa, Hironori Haga, Takashi Uchiyama.   

Abstract

We report a case of a 41-year-old male with human immunodeficiency virus (HIV)-associated lymphoproliferative disease (LPD) who was successfully treated with highly active antiretroviral therapy (HAART). He presented with epigastralgia, and an upper endoscopic examination revealed submucosal tumors and ulcerations in his stomach. Histopathologic examination of a biopsy specimen resulted in a diagnosis of diffuse large B-cell lymphoma. He also showed systemic lymphadenopathy; whereas, a concurrent inguinal lymph node biopsy produced a diagnosis of follicular hyperplasia. He was treated with CHOP chemotherapy but the response was poor. He demonstrated several immunological abnormalities, such as eosinophilia and bone marrow insufficiency, and was suspected to be in an immunocompromised state. He was examined for HIV infection and turned out to be positive. The gastric and inguinal lymph node specimens were re-evaluated and diagnoses of HIV-LPD and HIV lymphadenitis were made, respectively. He was treated with HAART and achieved complete remission and has remained tumor-free for 20 months. To the best of our knowledge, there is no previous report in which HIV-LPD was successfully treated with antiretroviral therapy alone. It is assumed that HAART resulted in the restoration of anti-tumor immunity in this case, which led to the eradication of LPD cells.

Entities:  

Mesh:

Year:  2010        PMID: 20217283     DOI: 10.1007/s12185-010-0542-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.

Authors:  G V Matthews; M Bower; S Mandalia; T Powles; M R Nelson; B G Gazzard
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

Authors:  François Boué; Jean Gabarre; Christian Gisselbrecht; Jacques Reynes; Antoine Cheret; Fabrice Bonnet; Eric Billaud; Martine Raphael; Remi Lancar; Dominique Costagliola
Journal:  J Clin Oncol       Date:  2006-08-08       Impact factor: 44.544

3.  Polymorphic lymphoid proliferation presenting as ileocecal intussusception.

Authors:  Xi Wang; Sunita Nathan; Rosalind Catchatourian; Harry Richter; Paula Kovarik
Journal:  Ann Hematol       Date:  2007-01-10       Impact factor: 3.673

4.  Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations.

Authors:  A Martin; J M Flaman; T Frebourg; F Davi; S El Mansouri; J Amouroux; M Raphaël
Journal:  Br J Haematol       Date:  1998-05       Impact factor: 6.998

5.  Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.

Authors:  Roland G Nador; Amy Chadburn; Girija Gundappa; Ethel Cesarman; Jonathan W Said; Daniel M Knowles
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

6.  Protease inhibitors potentiate chemotherapy-induced neutropenia.

Authors:  Mark Bower; Neil McCall-Peat; Natalie Ryan; Liz Davies; Anne Marie Young; Srirupa Gupta; Mark Nelson; Brian Gazzard; Justin Stebbing
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

7.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

8.  Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.

Authors:  Christian Hoffmann; Eva Wolf; Gerd Fätkenheuer; Thomas Buhk; Albrecht Stoehr; Andreas Plettenberg; Hans-Jürgen Stellbrink; Hans Jaeger; Uwe Siebert; Heinz-August Horst
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

9.  Persistent lymphadenopathies in people at high risk for HIV infection. Clinicopathologic correlations and long-term follow-up in 79 cases.

Authors:  H L Ioachim; W Cronin; M Roy; M Maya
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

Review 10.  Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases.

Authors:  B M Wenig; L D Thompson; S S Frankel; A P Burke; S L Abbondanzo; I Sesterhenn; D K Heffner
Journal:  Am J Surg Pathol       Date:  1996-05       Impact factor: 6.394

View more
  2 in total

1.  Polymorphic lymphoid proliferations occurring in HIV-positive patients: report of a case responding to HAART.

Authors:  Jenny Buxton; Clifford Leen; John R Goodlad
Journal:  Virchows Arch       Date:  2012-06-17       Impact factor: 4.064

Review 2.  Endoscopic appearance of AIDS-related gastrointestinal lymphoma with c-MYC rearrangements: case report and literature review.

Authors:  Shohei Tanaka; Naoyoshi Nagata; Sohtaro Mine; Toru Igari; Taiichiro Kobayashi; Jun Sugihara; Haruhito Honda; Katsuji Teruya; Yoshimi Kikuchi; Shinichi Oka; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.